Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only and is not medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before changing your diet, supplement regimen, or any health-related practice — particularly if you take anticoagulant medications.

Most coverage of natto’s health associations focuses on what comes out of the fermentation: nattokinase, vitamin K2, spermidine. Less discussed is the organism responsible — Bacillus subtilis var. natto — and what it does as a living microorganism in your gut. That question is worth examining separately, because this bacterium works through mechanisms that conventional probiotic strains do not.

Bacillus subtilis var. natto: a spore-former, not a conventional probiotic

The microorganism used in natto production is a domesticated strain of Bacillus subtilis, specifically Bacillus subtilis var. natto, selected over centuries of Japanese fermentation practice. A single 50g pack of fresh natto contains roughly 10^8 viable bacterial cells per gram — an exceptionally high live count for a food, and notably different from yogurt or kefir where lactic acid bacteria dominate.

What distinguishes B. subtilis var. natto from Lactobacillus or Bifidobacterium strains in commercial probiotics is biological category: it is a spore-forming bacterium. Under unfavorable conditions, including exposure to gastric acid and bile salts, Bacillus species can produce endospores — dormant structures with extremely high environmental resistance. Endospores survive the conditions that kill most live Lactobacillus strains.

This means that when you eat fresh natto, a substantial fraction of the bacteria arrive in the small intestine and colon in spore form, then germinate into vegetative (metabolically active) cells in the warmer, more nutrient-rich intestinal environment. This is the same property that has driven commercial interest in “spore-based probiotics” — a category that has expanded considerably over the past decade. Natto-origin B. subtilis strains have been incorporated into some of these supplement products precisely because spore form survives manufacturing, shelf storage, and gastric transit more reliably than fragile lactic acid bacteria.

In the gut, vegetative B. subtilis cells produce antimicrobial lipopeptides — including iturin A and fengycin, characterized in laboratory studies of the organism’s ecology — that appear to selectively suppress competing bacterial populations. Human studies examining competitive exclusion of pathogens by natto-origin B. subtilis specifically remain limited, and most mechanistic evidence comes from in vitro and animal models.

MK-7 synthesis: what the bacteria produce during fermentation

One of the most practically important things B. subtilis var. natto does is synthesize menaquinone-7 (MK-7), the long-chain form of vitamin K2, as a metabolic byproduct of fermentation. MK-7 is not added to natto; it accumulates as the bacteria metabolize soybeans over the 12–20 hours of active fermentation.

Quantitatively, 100g of fresh natto is estimated to contain approximately 850–1,000 mcg of MK-7, placing it among the highest dietary sources of this compound. The contrast with other vitamin K2 sources is meaningful: MK-4 (found in animal products including aged cheese, egg yolk, and some meats) has a plasma half-life measured in hours, while MK-7 has a half-life of approximately three days. This extended circulation time means that two to three natto servings per week can maintain detectable circulating MK-7 levels in ways that smaller, more frequent servings of higher-MK-4 foods may not.

The MK-7 evidence base — including bone mineral density associations and arterial calcification marker data — is covered separately in Nattokinase and Cardiovascular Evidence. The focus here is the bacterial organism and its gut effects, not the downstream cardiovascular literature.

JPHC cohort data: fermented soy and all-cause mortality

The Japan Public Health Center-Based Prospective Study (JPHC) tracked over 80,000 adults for roughly 25 years, documenting dietary patterns against mortality outcomes across multiple cohort phases. Several published analyses from this dataset have examined fermented soy intake — primarily miso and natto — and its association with all-cause and cause-specific mortality.

The pattern across analyses is broadly consistent: higher fermented soy intake is associated with reduced all-cause mortality in JPHC populations, with associations persisting after adjustment for age, sex, smoking, alcohol, physical activity, and total energy intake. What has drawn particular attention in the JPHC data is that natto appears to show this association more clearly than total soy intake does. People who ate more natto regularly did not simply eat more soy — tofu, the other major soy food in Japanese diets, does not show the same mortality associations in several analyses. That divergence has led researchers to examine what fermentation-specific factors may account for the difference: MK-7 bioavailability, nattokinase activity, and polyamines (spermidine’s role is reviewed in Japanese Spermidine, Longevity, and Natto) are the compounds most frequently proposed.

The essential calibration for JPHC data: these are observational associations, not controlled trials establishing cause and effect. People who eat natto regularly in Japan tend to have dietary and lifestyle patterns that differ from those who eat none in ways that are difficult to fully account for statistically. The consistency of the association across multiple JPHC analyses warrants attention; it does not establish that natto directly extends lifespan.

Gut flora modulation: what the intervention evidence shows

Short-term dietary intervention studies — typically 2–8 weeks, 20–60 participants — have examined how regular natto consumption is correlated with gut microbiome composition. The consistent finding across several published Japanese trials: Bifidobacterium proportions in the gut were higher during natto consumption periods relative to control or washout periods. These are narrow observation windows compared to the lifetime dietary exposures that characterize Japanese cohort populations, and the durability of these shifts after natto consumption stops has not been well characterized.

The mechanism linking B. subtilis to Bifidobacterium elevation is not fully established, but a plausible pathway involves the intestinal environment changes that accompany B. subtilis fermentative activity — including altered short-chain fatty acid profiles and pH adjustments that may favor Bifidobacterium over competing taxa.

Fresh natto also contains lactic acid bacteria directly, not as the dominant organism but as co-inhabitants of the fermentation environment. A naturally fermented 50g pack carries a mixed microbial community: B. subtilis var. natto at high density, plus lower numbers of lactic acid bacteria that survived the initial cooking, inoculation, and fermentation phases. This is structurally different from single-strain commercial probiotics, and harder to study as a single variable, which is part of why the intervention evidence base is narrower than supplement marketing around spore-based probiotics sometimes implies.

For the broader context of how Japanese fermented food diets are associated with gut microbiome patterns in centenarian and longitudinal cohort data — including what the diversity findings show and where the evidence runs thin — Japanese Gut Microbiome and Longevity: What the Research Actually Shows covers that ground.

Sourcing natto outside Japan

Fresh and frozen natto is the form most directly associated with JPHC dietary patterns and carries the highest MK-7 content. Frozen itohiki-natto (the stringy variety, in small polystyrene cups with mustard and tare sauce packets) is findable at Japanese specialty grocery stores — Mitsuwa, Marukai, and Tokyo Central locations in the US, and Korean supermarkets like H Mart that carry Japanese imports. For online purchase, Japanese specialty grocers are the more practical route than general Amazon search for fresh or frozen formats, as cold-chain shipping constraints limit availability.

Freeze-dried natto powder is shelf-stable and ships reliably. It retains MK-7 and polyamines in concentrated form; live bacterial content varies by production method and should not be assumed unless the product specifies viable colony counts on the label. On Amazon, search “freeze-dried natto powder” — verify the product is made from Bacillus subtilis var. natto-fermented soy rather than soy powder with natto flavoring.

MK-7 (vitamin K2) supplements provide the vitamin in isolated form at standardized doses, typically 100–200 mcg per serving. On iHerb, search “vitamin K2 MK-7 natto.” These contain no live bacteria and no nattokinase — they are specific to the K2 component and useful for people who want consistent K2 dosing or cannot tolerate natto’s flavor.

Bacillus subtilis probiotic capsules — on iHerb, search “Bacillus subtilis probiotic” — provide the spore-forming bacterial component in encapsulated form. Strain identity matters here: natto-origin B. subtilis strains differ from the DE111 and other commercial B. subtilis strains most often found in this category. Check whether the product specifies the strain and whether published human trial data exists for that specific strain, not just for Bacillus subtilis generically.

If you are interested in home fermentation — making natto from dried soybeans and a natto starter culture — the equipment and ingredient sourcing process has meaningful overlap with home miso and amazake production. Japanese Fermentation Starters: A Buyer’s Guide covers what is available internationally, including where to source dried koji and fermentation-grade soybeans outside Japan.

Before starting: the warfarin interaction and practical next steps

One contraindication warrants explicit attention before incorporating natto regularly: MK-7 has significant vitamin K activity and is linked to reduced anticoagulant efficacy of warfarin and related vitamin K-antagonist drugs. This is a documented, clinically meaningful drug-food interaction — not a theoretical risk. People who take warfarin, acenocoumarol, or phenprocoumon should consult their prescribing physician before adding natto or any vitamin K2 supplement to their diet.

For people without that contraindication: starting with fresh or frozen natto two to three times per week is closer to the dietary pattern associated with mortality outcomes in JPHC data than daily supplementation with natto extract. The food provides the full compound profile — MK-7, nattokinase, spermidine, live bacteria, prebiotic soy oligosaccharides — in the form that most of the observational evidence was built around.

If the flavor is a barrier — the fermented soybean smell and sticky, stringy texture are genuinely polarizing — freeze-dried natto powder blended into a smoothie or stirred into warm rice is a lower-commitment entry point. The compound profile is retained; the textural experience is not. Starting with the powder is a reasonable way to assess whether the dietary habit is sustainable before sourcing fresh formats.

---

Related reading: Nattokinase and Cardiovascular Evidence | Japanese Spermidine, Longevity, and Natto | Japanese Gut Microbiome Research | Japanese Fermentation Starters: A Buyer’s Guide